| Literature DB >> 22814567 |
Wilco C H Jacobs1, Mark P Arts, Maurits W van Tulder, Sidney M Rubinstein, Marienke van Middelkoop, Raymond W Ostelo, Arianne P Verhagen, Bart W Koes, Wilco C Peul.
Abstract
INTRODUCTION: Disc herniation with sciatica accounts for five percent of low-back disorders but is one of the most common reasons for spine surgery. The goal of this study was to update the Cochrane review on the effect of surgical techniques for sciatica due to disc herniation, which was last updated in 2007.Entities:
Mesh:
Year: 2012 PMID: 22814567 PMCID: PMC3481105 DOI: 10.1007/s00586-012-2422-9
Source DB: PubMed Journal: Eur Spine J ISSN: 0940-6719 Impact factor: 3.134
Search strings and date limits used for different databases for the updated search
| Database | Search stringsa | |||||||
|---|---|---|---|---|---|---|---|---|
| MEDLINE | Randomized controlled trial controlled clinical trial randomized placebo drug therapy randomly trial groups [animals not (humans and animals)] dorsalgia | Back Pain backache Low Back Pain (lumbar adj pain) coccyx coccydynia sciatica spondylosis lumbago Spine | Discitis Spinal Diseases (disc adj degeneration) (disc adj prolapse) (disc adj herniation) spinal fusion spinal neoplasms (facet adj joints) intervertebral disk postlaminectomy | Arachnoiditis (failed adj back) Cauda Equina (lumbar adj vertebraa) (spinal adj stenosis) [slipped adj (disca or diska)] [degenerata adj (disca or diska)] [stenosis adj (spine or root or spinal)] [displacea adj (disca or diska)] [prolapa adj (disca or diska)] | General Surgery Spinal Fusion Laminectomy Intervertebral Disk Displacement Bone Transplantation Intervertebral Disk Chemolysis Chymopapain Diskectomy [(spinea or spinal) adj decompressa] laminotomy | Laminoplasty Decompression, Surgical (pedicle adj screw) (facet adj fusion) (lateral adj mass) [(anterior or posterior) adj fusion] (bone adj graft) [fixation adj (spinea or spinal)] [stabilia adj (spinea or spinal)] (pedicle adj fusion) | Foraminotomy (forama adj stenosis) (lumbar adj body) (vertebra adj body) PLIF GRAF ligamentotaxis (cage adj fusion) (screw adj fusion) (pedicle adj screw) | Chemonucleolysis (cauda adj compressa) discectomy diskectomy Laser Therapy Enzymes/tu [Therapeutic Use] (enzymea adj injecta) [(intradisca or intradiska) adj (steroida or triamcinolone)] Collagenases/tu [Therapeutic Use] |
| EMBASE | Clinical Article Clinical Study Clinical Trial Controlled Study Randomized Controlled Trial Clinical Study Double Blind Procedure Multicenter Study | Single Blind Procedure Phase 3 Clinical Trial Phase 4 Clinical Trial crossover procedure placebo allocat$ assign$ blind$ | [clinic$ adj (study or trial)] compar$ control$ cross?over factorial$ follow?up placebo$ prospectiv$ | Random$ [(singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)] trial (versus or vs.) human Nonhuman exp ANIMAL Animal Experiment | Dorsalgia back pain LOW BACK PAIN exp BACKACHE (lumbar adj pain) coccyx coccydynia sciatica | ISCHIALGIA spondylosis lumbago SPINE discitis exp Spine Disease (disc adj degeneration) (disc adj prolapse) | (disc adj herniation) spinal fusion spinal neoplasms (facet adj joints) intervertebral disk postlaminectomy arachnoiditis (failed adj back) | Cauda Equina spinal stenosis spine surgery diskectomy discectomy Intervertebral Disk Hernia/su [Surgery] |
| CINAHL | Back Buttocks | Leg | Back Pain | Back Injuries | Low Back Pain | Sciatica | (low next back next pain) | lbp |
| CENTRAL | Back Pain dorsalgia backache Low Back Pain lumbar next pain coccyx coccydynia spondylosis Sciatica | Spine Spinal Diseases Lumbago Discitis disc near degeneration disc near prolapse disc near herniation spinal fusion spinal neoplasms | Facet near joints Intervertebral Disk postlaminectomy arachnoiditis failed near back Cauda Equina lumbar near vertebraa spinal near stenosis slipped near (disca or diska) | Degenerata near (disca or diska) stenosis near (spine or root or spinal) displacea near (disca or diska) prolapa near (disca or diska) Surgery Spinal Fusion Laminectomy Intervertebral Disk Displacement Bone Transplantation | Intervertebral Disk Chemolysis Chymopapain Diskectomy Decompression, Surgical (spinea or spinal) near decompressa Laminotomy Laminoplasty pedicle near screw facet near fusion | Lateral near mass anterior or posterior) near fusion bone near graft fixation near (spinea or spinal) stabilia near (spinea or spinal) pedicle near fusion foraminotomy forama near stenosis | Lumbar near body vertebra near body PLIF GRAF Ligamentotaxis cage near fusion screw near fusion pedicle adj screw | Chemonucleolysis cauda adj compressa Laser Therapy (discectomy) or (diskectomy) Enzymes Collagenases enzymea near injecta (intradisca or intradiska) near (steroida or triamcinolone) |
| PEDro | Clinical Trial :Controlled Clinical Trial Randomized Controlled Trial | Randoma placeboa sham | Versus vs “clinical trial” | “controlled trial” double-blind “double blind” | Single-blind “single blind” “BACK” | “BACK PAIN” “LOW BACK PAIN” “LUMBAR SPINE” “LUMBAR VERTEBRAE” | “SCIATICA” “low back pain” “back pain” | Sciatica “LUMBOSACRAL REGION” |
aFor readability we omitted connectors, search fields, explode options and multiple versions of the same search term in one database
Selection criteria
| Types of studies | Randomized controlled trials (RCT) |
| No fatal methodological flaw | |
| Full-text journal article | |
| Published in a peer reviewed journal | |
| Types of participants | Patients with sciatica due to disc herniation, who have indications for surgical intervention |
| Types of interventions | Comparisons between all types of surgical intervention were included, such as discectomy, micro-endoscopic-discectomy, automated percutaneous discectomy, nucleoplasty and laser discectomy. Any modifications to these interventional procedures were included, but alternative therapies such as nutritional or hormonal therapies were excluded |
| Types of outcome measures | All available outcomes were included, but patient centered outcomes were considered of primary interest: |
| Pain (Average on VAS or similar, or proportion improved) | |
| Recovery (Proportion of patients reporting recovery and/or as determined by a clinician) | |
| Function (Proportion of patients who had an improvement in function measured on a disability or quality of life scale) | |
| Return to work | |
| Rate of subsequent low back surgery | |
| Measures of objective physical impairment: Spinal flexion, improvement in straight leg raise, alteration in muscle power and change in neurological signs | |
| Adverse complications: Early: Damage to spinal cord, cauda equina, dural lining, a nerve root, or any combination; infection; vascular injury (including subarachnoid hemorrhage); allergic reaction to chymopapain; medical complications; death. Late: Chronic pain, altered spinal biomechanics, instability or both; adhesive arachnoiditis; nerve root dysfunction; myelocele; recurrent symptoms of sciatica due to disc herniation |
Criteria for risk of bias assessment
| Question | Criteria for “Yes” | Judgment | |
|---|---|---|---|
| A | 1. Was the method of randomization adequate? | A random (unpredictable) assignment sequence. Examples of adequate methods are coin toss, rolling a dice, drawing of ballots with the study group labels from a dark bag, computer-generated random sequence, pre-ordered sealed envelops, sequentially ordered vials Examples of inadequate methods are alternation, birth date, social insurance/security number, and hospital registration number | Yes/No/Unsure |
| B | 2. Was the treatment allocation concealed? | Assignments are generated by an independent person not responsible for determining the eligibility of the patients. This person has no information about the persons included in the trial and has no influence on the assignment sequence or on the eligibility decision of the patient | Yes/No/Unsure |
| C | 3. Was the patient blinded to the intervention? | The index and control groups are indistinguishable for the patients | Yes/No/Unsure |
| 4. Was the care provider blinded to the intervention? | The index and control groups are indistinguishable for the care providers | Yes/No/Unsure | |
| 5. Was the outcome assessor blinded to the intervention? | • For patient-reported outcomes with adequately blinded patients • For outcome criteria that supposes a contact between participants and outcome assessors: the blinding procedure is adequate if patients are blinded, and the treatment or adverse effects of the treatment cannot be noticed during examination • For outcome criteria that do not suppose a contact with participants: the blinding procedure is adequate if the treatment or adverse effects of the treatment cannot be noticed during the assessment • For outcome criteria that are clinical or therapeutic events that will be determined by the interaction between patients and care providers, in which the care provider is the outcome assessor: the report needs to be free of selective outcome reporting | Yes/No/Unsure | |
| D | 6. Was the drop-out rate described and acceptable? | The number of participants who were included in the study but did not complete the observation period or were not included in the analysis are described and reasons are given and are <20 % for short-term and <30 % for long-term follow-up | Yes/No/Unsure |
| 7. Were all randomized participants analyzed in the group to which they were allocated? | All randomized patients are reported/analyzed in the group they were allocated to by randomization for the most important moments of effect measurement (minus missing values) irrespective of non-compliance and co-interventions | Yes/No/Unsure | |
| E | 8. Are reports of the study free of suggestion of selective outcome reporting? | Yes/No/Unsure | |
| F | 9. Were the groups similar at baseline regarding the most important prognostic indicators? | The groups have to be similar at baseline regarding demographic factors, duration and severity of complaints, percentage of patients with neurological symptoms, and value of main outcome measure(s) | Yes/No/Unsure |
| 10. Were co-interventions avoided or similar? | There were no co-interventions or they were similar between the index and control groups | Yes/No/Unsure | |
| 11. Was the compliance acceptable in all groups? | The compliance with the interventions is acceptable, based on the reported intensity, duration, number and frequency of sessions for both the index intervention and control intervention(s). For single-session interventions (for ex: surgery), this item is irrelevant | Yes/No/Unsure | |
| 12. Was the timing of the outcome assessment similar in all groups? | Timing of outcome assessment was identical for all intervention groups and for all important outcome assessments | Yes/No/Unsure |
Fig. 1Flow chart for inclusion of studies
Risk of bias assessment of included studies
| Comparison | A1 | B2 | C3 | C4 | C5 | D6 | D7 | E8 | F9 | F10 | F11 | F12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study, Year | Randomisation | Allocation concealment | Patient blinding | Surgeon blinding | Outcome blinding | Drop-outs | ITT | Selective reporting | Baseline | Co interventions | Compliance | Outcome timing |
| Open versus minimal invasive discectomy | ||||||||||||
| Henriksen 1996 [ | + | − | + | − | + | + | ? | ? | + | + | + | + |
| Hermantin 1999 [ | + | ? | − | − | − | + | + | ? | + | ? | + | + |
| Huang 2005 [ | ? | ? | − | − | − | ? | ? | ? | ? | + | + | − |
| Katayama 2006 [ | + | ? | ? | − | ? | ? | ? | ? | ? | ? | + | − |
| Lagarrigue 1994 [ | + | + | − | − | + | ? | − | ? | + | ? | + | ? |
| Tullberg 1993 [ | ? | ? | − | − | − | + | − | ? | + | ? | + | + |
| Tureyen 2003 [ | + | ? | ? | ? | ? | − | ? | ? | + | ? | + | + |
| Teli 2010 [ | ? | ? | − | − | − | + | − | ? | + | + | + | + |
| Different techniques of minimal invasive discectomy | ||||||||||||
| Arts 2009 [ | + | + | + | − | + | + | + | ? | + | ? | + | + |
| Brock 2008 [ | − | − | + | − | + | ? | ? | ? | − | ? | + | ? |
| Franke 2009 [ | ? | ? | ? | − | ? | ? | ? | ? | + | ? | + | + |
| Mayer 1993 [ | ? | ? | − | − | − | + | ? | ? | + | ? | + | + |
| Righesso 2007 [ | ? | ? | − | − | − | ? | ? | ? | + | ? | + | + |
| Ryang 2008 [ | ? | ? | − | − | − | ? | ? | ? | + | ? | + | − |
| Shin 2008 [ | + | − | − | − | − | ? | ? | ? | ? | ? | + | + |
| Thome 2005 [ | + | + | ? | − | ? | + | − | ? | + | ? | + | + |
Quality of evidence for reported outcomes
| Comparison | Studies | Patients | Grade limitations | Summary of findings | Quantitative | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | Publication bias | Inconsistency | Indirectness | Imprecision | Risk of bias | Effect | Quality | Pooled effect | ||
| Open (OD) versus minimal invasive discectomy (MID) 6 studies | ||||||||||
| Surgery duration (min) | 6 | 612 | + | + | + | + | − | OD < MID | Moderate | MD 12.2 (2.20 to 22.3) |
| Length of stay (days) | 5 | 452 | + | + | + | + | − | OD <> MID | Moderate | MD −0.06 (−0.10 to +0.21) |
| Blood loss | 2 | 179 | − | + | + | − | − | OD ? MID | Very low | |
| Incision | 3 | 353 | + | − | + | + | − | OD > MID | Low | |
| Leg pain (mm VAS) | 4 | 453 | + | + | + | + | − | OD > MID | Moderate | MD −2.01 (−3.44 to −0.57) |
| Back pain (mm VAS) | 3 | 419 | − | − | + | + | − | OD ? MID | Very low | |
| Return to work | 3 | 254 | ? | − | + | + | − | OD ? MID | Very low | |
| Tubular (TD) versus microscopic discectomy (MID) 7 studies | ||||||||||
| Surgery duration (min) | 6 | 718 | + | − | + | − | − | TD ? MID | Very low | |
| Blood loss | 3 | 130 | − | + | + | − | − | TD ? MID | Very low | |
| Length of stay (days) | 4 | 528 | + | + | + | − | − | TD <> MID | Low | |
| Incision | 3 | 260 | + | + | + | ? | − | TD < MID | Low/Moderate | SD sparsely reported |
| Leg pain (mm VAS) | 3 | 548 | − | − | + | + | − | TD ? MID | Very low | |
| Back pain (mm VAS) | 4 | 703 | + | − | + | + | − | TD <> MID | Low | |
| Oswestry | 3 | 225 | ? | + | + | − | − | TD ? MID | Very low | |
| SF36 | 3 | 548 | ? | + | + | + | − | TD ? MID | Low | |
a< or > Effect is superior for one of both treatments; <> None of either treatments is superior; ? unclear relative effectiveness due to conflicting results
MD Mean difference, OR odds ratio
Characteristics of the included studies comparing open versus microscopic and comparable discectomy
| Author, year | Sample size | Female (%) | Average age (range/SD) | Participants | Interventions | Outcomes | Follow-up |
|---|---|---|---|---|---|---|---|
| Henriksen 1996 [ | 79 | 37 | 41 (30–48) | HNP, 20 to 60 years, failed conservative therapy (bed rest, analgesics,muscle relxers, physiotherapy), myelogram, CT verified | Open (standard) discectomy (OD) Microscopic discectomy (MD) | Incision, OP time, LOS Pain medication Pain (VAS) | 2, 4, 6 days 2, 4, 6 weeks |
| Hermantin 1999 [ | 60 | 35 | 40 (15–67) | Low back pain and radicular symptoms, confirmed by imaging, due to single level intercanalicular HNP at L2-S1. < 50 % canal, no osseous or ligamenteous stenosis, failed conservative treatment, back pain > leg pain, no severe disc height loss | Open laminectomy and discectomy (OD) Video assisted arthroscopic microdiscectomy (VAMD) | Self evaluation Physical examination Return to function Pain (Houde) Satisfaction Return to work | 2 weeks 3, 6 months 1, 2 years |
| Huang 2005 [ | 22 | 32 | 39.4 (10.9) | Failed conservative treatment (3 months), OR Acute attack of intractable back and leg pain, no improvement 1–2 weeks bedrest. No motor deficit or sphincter disturbance | Open discectomy (OD) Microendoscopic discectomy (MED) | OP time, Blood loss, LOS Interleukines and CRP Pain (VAS) MacNab | 18.9 months (10–25) |
| Katayama 2006 [ | 119 | 36 | 37 (14–65) | Primary surgery for HNP | Open (macro) discectomy (OD) Microscopic discectomy (MD) | OP time, Blood loss, LOS Pain medication JOA VAS back pain VAS sciatica Complications/reoperations | 2.67 years (1–4) |
| Lagarrigue 1994 [ | 80 | 49 | 43 (15–80) | HNP with sciatica, failed conservative treatment (3 months), CT confirmed. No paralysis, stenosis, degenerative changes | Open discectomy (OD) Microscopic disectomy (MD) | MacNab OP time, LOS RTW | 14.9 months (12–18) |
| Teli 2010 [ | 240 | 34 | 39.3 (27–61) | Symptomatic, single-level HNP, 18–65 years, concordant neurological signs, failed conservative treatment (6 weeks, pain medication, epidural steroids), no additional spinal disorders | Open discectomy (OD) Microscopic discectomy (MD) Microendoscopic discectomy (MED) | OP time, Incision Back pain (VAS) Leg pain (VAS) Oswestry disability SF36 Cost | 10 days 6, 12, 24 months |
| Tullberg 1993 [ | 60 | 35 | 39 (17–64) | Single lumbar disc herniation, failed conservative treatment (2 months), CT verified | Open (standard) discectomy (OD) Microscopic discectomy (MD) | OP time, Blood loss, LOS Back pain (VAS) Leg pain (VAS) Satisfaction | 3 weeks 2, 6, 12 months |
| Tureyen 2003 [ | 114 | 43 | 41.6 (18–61) | Lumbar disc herniation, leg pain, MRI verified | Laminectomy and macrodiscectomy (OD) Microscopic discectomy (MD) | OP time, LOS, incision Radicular pain (VAS) Muscle strength (MRC) Sensation Reflex | 10 days 1 month 1 year |
LOS Length of stay, RTW Return to work, JOA Japanese Orthopaedic Association score
Results of the included studies: open discectomy versus microscopic discectomy for disc herniations with sciatica
| Author, year | Group | Crossover ( | Surgical morbidity | Pain (VAS in mm) (sd, range) at 2 years | Recovery/Clinical outcome at 2 years# | Qualitative conclusions | |||
|---|---|---|---|---|---|---|---|---|---|
| OP time | Blood loss (gr or ml) | LOS (days) | Incision | ||||||
| Henriksen 1996 [ | Open (standard) discectomy (OD) | 0 | 35 (30–40) | – | 4.6 (3–7) | Skin: 71 (2.5) Fascia: 70 (2.0) | Not extractable, no difference | – | Shorter incision does not affect LOS or pain |
| Microscopic discectomy (MD) | 0 | 48 (37–60) | 5.2 (3–6) | Skin: 72 (2.5) Fascia: 31 (2.5) | |||||
| Katayama 2006 [ | Open (macro) discectomy (OD) | ? | 40 (12) | 39 (11) | 8.3 (0.8) | – | VAS lumbar at 2.7 years: 16 (7) VAS sciatica at 2.7 years: 13 (5) | JOA at 2.7 years: 27 (1) | Small differences in OP time, blood loss, hospitalization. No difference in analgesics. Long term: Small difference in VAS lumbar pain. No differences in VAS sciatica or JOA |
| Microscopic discectomy (MD) | ? | 45 (8) | 25 (9) | 8.5 (2.3) | VAS lumbar at 2.7 years: 12 (04) VAS sciatica at 2.7 years: 12 (04) | JOA at 2.7 years: 27 (1) | |||
| Lagarrigue 1994 [ | Open discectomy (OD) | ? | 60 | – | 6.5 | – | – | MacNab at 14.9 months 90 % RTW at 14.9 months: 77 days | No difference in clinical outcome, operating time, hospital stay, or return to work |
| Microscopic discectomy (MD) | ? | 65 | 6.2 | MacNab at 14.9 months: 90 % RTW at 14.9 months: 94 days | |||||
| Tullberg 1993 [ | Open (standard) discectomy (OD) | 0 | 46 (20–95) | 45 (10–200) | 2.3 (1–5) | – | VAS leg pain at 1 year: 23 VAS back pain at 1 year: 18 | Sick leave: 10.1 weeks Recovery: 90 % | No differences in bleeding, complications, LOS, sick leave and clinical outcomes (pain and recovery) |
| Microscopic discectomy (MD) | 0 | 60 (25–90) | 47 (10–200) | 2.5 (1–3) | VAS leg: 21 VAS back: 16 | Sick leave: 10.4 weeks Recovery: 86 % | |||
| Tureyen 2003 [ | Laminectomy and macrodiscectomy (OD) | ? | 25 (20–90, 7.07) | – | 1 (1–2) | 6 (5–7) | Radicular pain (VAS): 14 (0–30) | RTW at 4 weeks: 54 % | Differences in incison and operative time and earlier return to work, and analgesics use. No further differences |
| Microscopic discectomy (MD) | ? | 54 (25–95, 5.25) | 1 (1–2) | 4 (3–5) | Radicular pain (VAS): 12 (0–30) | RTW at 4 weeks: 88 % | |||
| Teli 2010 [ | Open discectomy (OD) | ? | 36 (10) | – | – | Skin: 23 | VAS leg pain: 20 (10) VAS back pain: 10 (10) | Oswestry: 14 (5) | Comparable outcome, MED more costly and more complications |
| Microscopic discectomy (MD) | ? | 43 (8) | Skin: 22 | VAS leg pain: 20 (10) VAS back pain: 20 (10) | Oswestry: 13 (5) | ||||
| Microendoscopic discectomy (MED) | ? | 56 (12) | Skin: 10 | VAS leg pain: 20 (10) VAS back pain: 20 (10) | Oswestry: 15 (5) | ||||
| Huang 2005 [ | Open discectomy (OD) | 0 | 72.1 (17.8) | 190 (115) | 5.92 (2.39) | 6.3 (0.98) | VAS at 18.9 Months 14 (01,10–30) | MacNab at 18.9 months: 90 % | Surgical trauma is less with MED than OD. Clinical outcomes are comparable |
| Microendoscopic discectomy (MED) | 1a | 109 (35.9) | 87.5 (69.4) | 3.57 (0.98) | 1.86 (0.13) | VAS 15 (02, 10–20) | MacNab at 18.9 months: 91.6 % | ||
| Hermantin 1999 [ | Open discectomy (OD) | 0 | – | – | – | – | According to Houde: 1.9 | RTW/resume normal activity: 49 days Good outcome: 93 % | Same satisfactory outcome; VAMD shorter disability |
| Video assisted MD (VAMD) | 0 | According to Houde: 1.2 | RTW/resume normal activity: 27 days Good outcome: 97 % | ||||||
LOS Length of stay, RTW Return to work, JOA Japanese Orthopaedic Association score
aOne patient insisted on OD; the text is ot clear if this patient was randomized to MED or not randomized at all
Fig. 2Forest plot for VAS leg pain between microscopic discectomy and open discectomy
Fig. 3Forest plot for operating time between microscopic discectomy and open discectomy
Fig. 4Forest plot for length of stay between microscopic discectomy and open discectomy
Characteristics of the included studies comparing different techniques of minimal invasive discectomy
| Author, year | Sample size | Female (%) | Average age (range/SD) | Participants | Interventions | Outcomes | Follow-up |
|---|---|---|---|---|---|---|---|
| Arts 2009 [ | 328 | 47 | 41.5 (18–70, 10.8) | HNP + persistent radicular pain (>8 weeks). Unsuccessful conservative treatment. The Netherlands | Transmuscular tubular microscopic discectomy Conventional microscopic discectomy | OP time, blood loss, LOS Roland-Morris (RMDQ) Back pain (VAS) Leg pain (VAS) SF36 Sciatica frequency and bothersome (SFBI) Recovery (self-reported) Muscle injury Cost effectiveness | 2, 4, 6, 8, 12, 26, 38 weeks 1, 2 years |
| Brock 2008 [ | 125 | 49 | 51 (20–79) | First time lumbar microdiscectomy, failed conservative treatment (12 weeks). Germany | Subperiosteal microscopic discectomy Transmuscular microscopic discectomy | Leg Pain (VAS) Back pain (VAS) Oswestry LOS Analgesics use | 1, 6 days before discharge |
| Franke 2009 [ | 100 | 40 | 44 (21–72, 11.7) | Disc dislocations grades 3–5 (Kramer), no lateral HNP, no protrusions | Microscopic discectomy Microscopically Assisted Percutaneous Nucleotomy | OP time, LOS RTW Oswestry Back pain (VAS) Leg pain (VAS) Neurological deficits | 8 weeks 6, 12 months |
| Mayer 1993 [ | 40 | 35 | 41.3 (12–63, 10.2) | Previous unsuccessful conservative treatment (time period not stated). Only small “non-contained” disc herniations included. Berlin, Germany | Percutaneous Endoscopic Discectomy Micro-surgical discectomy | OP time Patient rating Surgeon rating | 2 years |
| Righesso 2007 [ | 40 | 43 | 43.9 (11.5) | Posterolateral HNP and persistence of sciatica, failed conservative treatment (4–8 weeks) with rest, analgesia, NSAIDs and physical therapy. MRI verified. Brazil | Microendoscopic discectomy Open discectomy with loupe | OP time, Blood loss, LOS Incision Pain (VAS) Oswestry Neurological status | 12 h 1, 3, 6, 12, 24 months |
| Ryang 2008 [ | 60 | 47 | 38.7 (21–69, 10.3) | Single level virgin HNP; typical monoradicular symptoms, sciatica > > lower back pain, failed conservative treatment (8 to 12 weeks). Germany | Minimal access microscopic discectomy Open microscopic discectomy | Pain: VAS (10 cm) Oswestry SF-36 | 16 months (6–26) |
| Shin 2008 [ | 30 | 60 | 45.4 (14.6) | Single-level unilateral HNP, failed conservative treatment (> 6 weeks), CT or MRI verified. Korea | Microendoscopic discectomy Microscopic discectomy | Back pain (VAS) Leg pain (VAS) Blood enzymes (CPK, LDH) | 1, 3 and 5 days |
| Teli 2010 [ | See Table | ||||||
| Thome 2005 [ | 84 | 44 | (18–60) | Single level HNP, failed conservative treatment, 18-60 years, MRI verified. Mannheim, Germany | Disc sequestrectomy Microscopic discectomy | OP time, blood loss Patient satisfaction index Prolo scale SF-36 Low back pain (VAS) Sciatica (VAS) Repeat surgery | Discharge 4–6 months 12–18 months 2-years |
LOS length of stay, RTW Return to work
Results of the included studies: Different techniques for minimal invasive discectomy for disc herniations with sciatica
| Author, year | Group | Crossover ( | OP time (mins) | Blood loss (gr or ml) | LOS (days) | Incision (cm) | Pain (VAS in mm) (sd, range) at 2 years | Recovery/Clinical outcome at 2 years# | Qualitative conclusions |
|---|---|---|---|---|---|---|---|---|---|
| Arts 2009 [ | Conventional microdiscectomy (MD) | 2 | 36 (16) | % <50 ml: 85 | 3.3 (1.1) | – | VAS leg pain 14.0 (se 1.8) VAS back pain 19.4 (se 1.9) | RMDQ: 3.7 (se 0.5) SF 36: physical 82.4 (se 1.8) | TD bit more leg and back pain, other outcomes not different. Not less muscle injury |
| Transmuscular tubular discectomy (TD) | 2 | 47 (22) | % < 50 ml: 92 | 3.3 (1.2) | VAS leg pain 15.3 (se 1.7) VAS back pain 23.5 (se 1.9) | RMDQ: 4.5 (se 0.5) SF36: 78.9 (se 1.7) | |||
| Brock 2008 [ | Subperiosteal microdiscectomy (MD) | ? | – | – | – | – | VAS leg pain discharge: 14 VAS back pain discharge: 17 | Oswestry at discharge: 20 | Analgesics consumption less with transmuscular approach. Pain and Oswestry similar |
| Transmuscular discectomy (TD) | ? | VAS leg pain discharge: 9 VAS back pain discharge: 12 | Oswestry at discharge: 25.7 | ||||||
| Franke 2009 [ | Microscopic Discectomy (MD) | 0 | 56.3 (19.2) | – | 4.9 | – | – | – | Shorter OP time and quicker recovery at experienced center for MAPN. No clinical or complication rate differences |
| Percutaneous Nucleotomy (MAPN) | 0 | 41.8 (15.5) | 3.8 | ||||||
| Mayer 1993 [ | Micro-discectomy (MD) | 0 | 58.2 (15.2) | – | – | – | – | Clinical score: 7.67 (1.9) | Clinical results comparable, in some respects percutaneous superior |
| Percutaneous Endoscopic Discectomy (PED) | 0 | 40.7 (11.3) | Clinical score: 8.23 (1.3) | ||||||
| Righesso 2007 [ | Open discectomy with loupe (MD) | ? | 63.7 (15.5) | 40 (11–450) | 26 (16–72) h | 2.6 (0.4) | VAS: 0 (0–60) | Oswestry: 10 (0–30) | MD longer LOS and incision, MED longer OP time. No clinical differences |
| Microendoscopic discectomy (MED) | ? | 82.6 (21.9) | 50 (10–700) | 24 (11–72) h | 2.1 (0.2) | VAS: 10 (0–30) | Oswestry: 10 (0–22) | ||
| Ryang 2008 [ | Open microscopic discectomy (MD) | 0 | 92 (33–150, 28.6) | 63.8 (0–300, 86.8) | 4.4 (1–15, 2.8) | 4–5 | VAS Back pain at 16 months: 21 (0–98, 24) | Oswestry at 16 months: 12 (0–86, 18.8) SF 36: at 16 months physical 47.5 (9.4) and mental 51.9 (7.8) | No differences |
| Minimal access microdiscectomy (MAD) | 0 | 82 (37–120, 25.1) | 26.2 (0–100, 29.7) | 4 (2–14, 2.3) | 1.6 | VAS Back pain at 16 months: 21 (0–75, 24) | Oswestry at 16 months: 12 (0–46, 14) SF36: Physical 47.6 (10.7) and mental 44 (13.2) | ||
| Shin 2008 [ | Microscopic discectomy (MD) | ? | 47 (5) | 34 (11) | – | – | VAS Back at 5 days: 36 (11) VAS leg at 5 days: 24 (21) | – | MED faster relief of back pain within the first 5 days post-operatively, but no differences in leg pain |
| Microendoscopic discectomy (MED) | ? | 49 (5) | 35 (9) | VAS Back at 5 days: 19 (11) VAS leg at 5 days: 25 (16) | |||||
| Teli 2010 [ | Microscopic discectomy (MD) | ? | 43 (8) | – | – | 2.2 | VAS leg pain: 20 (10) VAS back pain: 20 (10) | SF36: 13 (5) | MED more costly and more complications |
| Microendoscopic discectomy (MED) | ? | 56 (12) | 1.0 | VAS leg pain: 20 (10) VAS back pain: 20 (10) | SF 36: 15 (5) | ||||
| Thome 2005 [ | Microdiscectomy (MD) | 38.2 (10.3) | 78.2 (61.6) | – | – | – | – | Clinical results favoring sequestrectomy | |
| Disc sequestrectomy (DS) | 32.6 (13.8) | 67.0 (85.4) |
Average given, with in brackets range (xx–xx) or sd (xx) or both (xx–xx, xx), or se when indicated. Follow-up as in column headers, unless indicated otherwise
LOS Length of stay